The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Longevity and Anti-senescence Therapy Market Research Report 2025
Synopsis
Aging is a natural process, yixue anti-aging, refers to some with inhibition, delay the aging process of the body, can promote the overall health, make the body in the genetic factors within the life limit to maintain a better intelligence and physical strength.Aging, however much you may be reluctant to do it, is a natural part of life.Skin can appear as the lapse of years a variety of problems are like furrow, flabby, chromatic spot, dark dumb etc.Anti-aging is to help reduce the production of free radicals and increase skin elasticity by supplementing antioxidant substances, while supplementing collagen or enzyme, anti-aging dietary therapy and anti-aging skin care products can effectively delay aging.
The global Longevity and Anti-senescence Therapy market was valued at US$ 318.4 million in 2023 and is anticipated to reach US$ 566.4 million by 2030, witnessing a CAGR of 8.1% during the forecast period 2024-2030.
North American market for Longevity and Anti-senescence Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Longevity and Anti-senescence Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Longevity and Anti-senescence Therapy in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Longevity and Anti-senescence Therapy include Bristol Myers Squibb, CohBar, Life Biosciences, AgeX Therapeutics, Unity Biotechnology, Calico Life Sciences, Oisin Biotechnologies, T.A. Sciences and BioAge Labs, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Longevity and Anti-senescence Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Longevity and Anti-senescence Therapy.
Report Scope
The Longevity and Anti-senescence Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Longevity and Anti-senescence Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Longevity and Anti-senescence Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol Myers Squibb
CohBar
Life Biosciences
AgeX Therapeutics
Unity Biotechnology
Calico Life Sciences
Oisin Biotechnologies
T.A. Sciences
BioAge Labs
Retro Biosciences
Senolytic Therapeutics
Segment by Type
Drug Therapy
Gene Therapy
Immunotherapy
Others
Segment by Application
Hospital
Medical Service Institution
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Longevity and Anti-senescence Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Aging is a natural process, yixue anti-aging, refers to some with inhibition, delay the aging process of the body, can promote the overall health, make the body in the genetic factors within the life limit to maintain a better intelligence and physical strength.Aging, however much you may be reluctant to do it, is a natural part of life.Skin can appear as the lapse of years a variety of problems are like furrow, flabby, chromatic spot, dark dumb etc.Anti-aging is to help reduce the production of free radicals and increase skin elasticity by supplementing antioxidant substances, while supplementing collagen or enzyme, anti-aging dietary therapy and anti-aging skin care products can effectively delay aging.
The global Longevity and Anti-senescence Therapy market was valued at US$ 318.4 million in 2023 and is anticipated to reach US$ 566.4 million by 2030, witnessing a CAGR of 8.1% during the forecast period 2024-2030.
North American market for Longevity and Anti-senescence Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Longevity and Anti-senescence Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Longevity and Anti-senescence Therapy in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Longevity and Anti-senescence Therapy include Bristol Myers Squibb, CohBar, Life Biosciences, AgeX Therapeutics, Unity Biotechnology, Calico Life Sciences, Oisin Biotechnologies, T.A. Sciences and BioAge Labs, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Longevity and Anti-senescence Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Longevity and Anti-senescence Therapy.
Report Scope
The Longevity and Anti-senescence Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Longevity and Anti-senescence Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Longevity and Anti-senescence Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol Myers Squibb
CohBar
Life Biosciences
AgeX Therapeutics
Unity Biotechnology
Calico Life Sciences
Oisin Biotechnologies
T.A. Sciences
BioAge Labs
Retro Biosciences
Senolytic Therapeutics
Segment by Type
Drug Therapy
Gene Therapy
Immunotherapy
Others
Segment by Application
Hospital
Medical Service Institution
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Longevity and Anti-senescence Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Longevity and Anti-senescence Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Drug Therapy
1.2.3 Gene Therapy
1.2.4 Immunotherapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Longevity and Anti-senescence Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Medical Service Institution
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Longevity and Anti-senescence Therapy Market Perspective (2019-2030)
2.2 Longevity and Anti-senescence Therapy Growth Trends by Region
2.2.1 Global Longevity and Anti-senescence Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Longevity and Anti-senescence Therapy Historic Market Size by Region (2019-2024)
2.2.3 Longevity and Anti-senescence Therapy Forecasted Market Size by Region (2025-2030)
2.3 Longevity and Anti-senescence Therapy Market Dynamics
2.3.1 Longevity and Anti-senescence Therapy Industry Trends
2.3.2 Longevity and Anti-senescence Therapy Market Drivers
2.3.3 Longevity and Anti-senescence Therapy Market Challenges
2.3.4 Longevity and Anti-senescence Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Longevity and Anti-senescence Therapy Players by Revenue
3.1.1 Global Top Longevity and Anti-senescence Therapy Players by Revenue (2019-2024)
3.1.2 Global Longevity and Anti-senescence Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Longevity and Anti-senescence Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Longevity and Anti-senescence Therapy Revenue
3.4 Global Longevity and Anti-senescence Therapy Market Concentration Ratio
3.4.1 Global Longevity and Anti-senescence Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Longevity and Anti-senescence Therapy Revenue in 2023
3.5 Longevity and Anti-senescence Therapy Key Players Head office and Area Served
3.6 Key Players Longevity and Anti-senescence Therapy Product Solution and Service
3.7 Date of Enter into Longevity and Anti-senescence Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Longevity and Anti-senescence Therapy Breakdown Data by Type
4.1 Global Longevity and Anti-senescence Therapy Historic Market Size by Type (2019-2024)
4.2 Global Longevity and Anti-senescence Therapy Forecasted Market Size by Type (2025-2030)
5 Longevity and Anti-senescence Therapy Breakdown Data by Application
5.1 Global Longevity and Anti-senescence Therapy Historic Market Size by Application (2019-2024)
5.2 Global Longevity and Anti-senescence Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Longevity and Anti-senescence Therapy Market Size (2019-2030)
6.2 North America Longevity and Anti-senescence Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Longevity and Anti-senescence Therapy Market Size by Country (2019-2024)
6.4 North America Longevity and Anti-senescence Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Longevity and Anti-senescence Therapy Market Size (2019-2030)
7.2 Europe Longevity and Anti-senescence Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Longevity and Anti-senescence Therapy Market Size by Country (2019-2024)
7.4 Europe Longevity and Anti-senescence Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Longevity and Anti-senescence Therapy Market Size (2019-2030)
8.2 Asia-Pacific Longevity and Anti-senescence Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Longevity and Anti-senescence Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Longevity and Anti-senescence Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Longevity and Anti-senescence Therapy Market Size (2019-2030)
9.2 Latin America Longevity and Anti-senescence Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Longevity and Anti-senescence Therapy Market Size by Country (2019-2024)
9.4 Latin America Longevity and Anti-senescence Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Longevity and Anti-senescence Therapy Market Size (2019-2030)
10.2 Middle East & Africa Longevity and Anti-senescence Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol Myers Squibb
11.1.1 Bristol Myers Squibb Company Detail
11.1.2 Bristol Myers Squibb Business Overview
11.1.3 Bristol Myers Squibb Longevity and Anti-senescence Therapy Introduction
11.1.4 Bristol Myers Squibb Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.1.5 Bristol Myers Squibb Recent Development
11.2 CohBar
11.2.1 CohBar Company Detail
11.2.2 CohBar Business Overview
11.2.3 CohBar Longevity and Anti-senescence Therapy Introduction
11.2.4 CohBar Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.2.5 CohBar Recent Development
11.3 Life Biosciences
11.3.1 Life Biosciences Company Detail
11.3.2 Life Biosciences Business Overview
11.3.3 Life Biosciences Longevity and Anti-senescence Therapy Introduction
11.3.4 Life Biosciences Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.3.5 Life Biosciences Recent Development
11.4 AgeX Therapeutics
11.4.1 AgeX Therapeutics Company Detail
11.4.2 AgeX Therapeutics Business Overview
11.4.3 AgeX Therapeutics Longevity and Anti-senescence Therapy Introduction
11.4.4 AgeX Therapeutics Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.4.5 AgeX Therapeutics Recent Development
11.5 Unity Biotechnology
11.5.1 Unity Biotechnology Company Detail
11.5.2 Unity Biotechnology Business Overview
11.5.3 Unity Biotechnology Longevity and Anti-senescence Therapy Introduction
11.5.4 Unity Biotechnology Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.5.5 Unity Biotechnology Recent Development
11.6 Calico Life Sciences
11.6.1 Calico Life Sciences Company Detail
11.6.2 Calico Life Sciences Business Overview
11.6.3 Calico Life Sciences Longevity and Anti-senescence Therapy Introduction
11.6.4 Calico Life Sciences Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.6.5 Calico Life Sciences Recent Development
11.7 Oisin Biotechnologies
11.7.1 Oisin Biotechnologies Company Detail
11.7.2 Oisin Biotechnologies Business Overview
11.7.3 Oisin Biotechnologies Longevity and Anti-senescence Therapy Introduction
11.7.4 Oisin Biotechnologies Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.7.5 Oisin Biotechnologies Recent Development
11.8 T.A. Sciences
11.8.1 T.A. Sciences Company Detail
11.8.2 T.A. Sciences Business Overview
11.8.3 T.A. Sciences Longevity and Anti-senescence Therapy Introduction
11.8.4 T.A. Sciences Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.8.5 T.A. Sciences Recent Development
11.9 BioAge Labs
11.9.1 BioAge Labs Company Detail
11.9.2 BioAge Labs Business Overview
11.9.3 BioAge Labs Longevity and Anti-senescence Therapy Introduction
11.9.4 BioAge Labs Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.9.5 BioAge Labs Recent Development
11.10 Retro Biosciences
11.10.1 Retro Biosciences Company Detail
11.10.2 Retro Biosciences Business Overview
11.10.3 Retro Biosciences Longevity and Anti-senescence Therapy Introduction
11.10.4 Retro Biosciences Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.10.5 Retro Biosciences Recent Development
11.11 Senolytic Therapeutics
11.11.1 Senolytic Therapeutics Company Detail
11.11.2 Senolytic Therapeutics Business Overview
11.11.3 Senolytic Therapeutics Longevity and Anti-senescence Therapy Introduction
11.11.4 Senolytic Therapeutics Revenue in Longevity and Anti-senescence Therapy Business (2019-2024)
11.11.5 Senolytic Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
